The Supreme Court Decisions Impacting Pharmacy Industry, Agency Interactions | ASPL 2024
Selina Coleman, JD, Partner in Life Sciences Health Industry Group at Reed Smith LLP, discussed recent developments in Supreme Court decisions impacting pharmacy operations.
FDA Aligns with Pharmacists in Ensuring Integrity of Drug Supply Chain | ASPL 2024
An FDA representative gave a presentation on her organization’s recent updates regarding drug supply chain rules and regulations.
How DSCSA Serves as the Drug Supply Chain’s Lead Investigator | ASPL 2024
Pharmacy law experts detailed the Drug Supply Chain Security Act, highlighting the role each entity within the supply chain plays in ensuring the safety and authenticity of US prescription drugs.
The Nuances of Marijuana’s Potential Rescheduling | ASPL 2024
FDA experts gathered to discuss the DEA’s rescheduling of marijuana and how it will impact the pharmaceutical supply chain.
Prescription Drugs in the US Must Be Viewed as Critical Infrastructure | ASPL 2024
Stephen Schondelmeyer, PharmD, PhD, FAPhA, gave a presentation on US drug shortages and their global implications.
Corresponding Responsibility of Pharmacies, DEA to Uphold Controlled Substances Act | ASPL 2024
Joel Ferre, JD, Assistant United States Attorney in Utah, led a discussion covering the DEA and pharmacies’ roles in reporting red flags when dispensing medication.
